• 中药标准品生产商,产品定制服务
  • 对羟基肉桂酸

    p-Hydroxy-cinnamic acid

    对羟基肉桂酸
    产品编号 CFN98179
    CAS编号 7400-08-0
    分子式 = 分子量 C9H8O3 = 164.16
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Phenylpropanoids
    植物来源 The barks of Cinnamomum cassia Presl
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    对羟基肉桂酸 CFN98179 7400-08-0 10mg QQ客服:3257982914
    对羟基肉桂酸 CFN98179 7400-08-0 20mg QQ客服:3257982914
    对羟基肉桂酸 CFN98179 7400-08-0 50mg QQ客服:3257982914
    对羟基肉桂酸 CFN98179 7400-08-0 100mg QQ客服:3257982914
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • University of Indonesia (Indonesia)
  • Massachusetts General Hospital (USA)
  • Martin Luther University of Halle-Wittenberg (Germany)
  • University of Toulouse (France)
  • Georgia Institute of Technology (USA)
  • National Chung Hsing University (Taiwan)
  • University of Wisconsin-Madison (USA)
  • University of Zurich (Switzerland)
  • Max Rubner-Institut (MRI) (Germany)
  • Kitasato University (Japan)
  • University of Wollongong (Australia)
  • Universidad Miguel Hernández (Spain)
  • University of Pretoria (South Africa)
  • Universidade Federal de Pernambuco (UFPE) (Brazil)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Food Chem.2016, 191:81-90
  • Chem Biol Interact.2016, 260:168-175
  • Phytochem Anal.2016, 27(5):296-303
  • Kor. J. Pharmacogn.2016, 47(1):62-72
  • PLoS One.2017, 12(8):e0181191
  • J Ethnopharmacol.2017, 197:157-164
  • J Food Compos Anal2017, 62:197-204
  • J Sci Food Agric.2017, 97(5):1656-1662
  • ACS Nano.2018, 12(4):3385-3396
  • PLoS One.2018, 13(4):e0195642
  • The Pharmaceutical Society of Japan2018, 138(4):571-579
  • Integr Cancer Ther.2018, 17(3):832-843
  • International Food Research Journal2018, 25(6):2560-2571
  • Sci Rep. 2018, 462(8)
  • Planta Med.2018, 84(15):1101-1109
  • Biomed Pharmacother.2019, 111:262-269
  • Int J Mol Sci.2019, 20(23):E6071
  • Molecules.2019, 24(6):E1155
  • J of the Korean Society of Food Science and Nutrition2019, 32(2):148-154
  • Oncol Rep.2019, 41(4):2453-2463
  • TCI CO.2019, US20190151281A1
  • Neurochem Int.2020, 133:104629
  • Food Chem.2020, 313:126079
  • ...
  • 生物活性
    Description: p-Hydroxy-cinnamic acid may have in vitro antimalarial activity. p-Hydroxycinnamic acid and β-cryptoxanthin have anti-osteoporotic properties in vivo, they can antagonize NF-κB activation in MC3T3 preosteoblastic cells。
    Targets: NF-kB | Antifection
    In vitro:
    Parasitol Res. 2012 Feb;110(2):539-44.
    Antimalarial drug interactions of compounds isolated from Kigelia africana (Bignoniaceae) and their synergism with artemether, against the multidrug-resistant W2mef Plasmodium falciparum strain.[Pubmed: 21814840]
    For decades, drug resistance has been the major obstacle in the fight against malaria, and the search for new drugs together with the combination therapy constitutes the major approach in responding to this situation.
    METHODS AND RESULTS:
    The present study aims at assessing the in vitro antimalarial activity of four compounds isolated from Kigelia africana stem bark (atranorin - KAE1, specicoside - KAE7, 2β,3β,19α-trihydroxy-urs-12-20-en-28-oic acid - KAE3, and p-hydroxy-cinnamic acid - KAE10) and their drug interactions among themselves and their combination effects with quinine and artemether. The antiplasmodial activity and drug interactions were evaluated against the multidrug-resistant W2mef strain of Plasmodium falciparum using the parasite lactate dehydrogenase assay. Three of the four compounds tested were significantly active against W2mef: specicoside (IC(50) = 1.02 ± 0.17 μM), 2β,3β,19α-trihydroxy-urs-12-en-28-oic acid (IC(50) = 1.86 ± 0.15 μM) and atranorin (IC(50) = 1.78 ± 0.18 μM), whereas p-hydroxy-cinnamic acid showed a weak activity (IC(50) = 12.89 ± 0.87 μM). A slight synergistic effect was observed between atranorin and 2β,3β,19α-trihydroxy-urs-12-en-28-oic acid (Combination index, CI = 0.82) whereas the interaction between specicoside and p-hydroxy-cinnamic acid were instead antagonistic (CI = 2.67).
    CONCLUSIONS:
    All the three compounds showed synergistic effects with artemether, unlike the slight antagonistic interactions of atranorin and 2β,3β,19α-trihydroxy-urs-12-en-28-oic acid in combination with quinine. K. africana compounds are therefore likely to serve as leads in the development of new partner drugs in artemether-based combination therapy.
    Nat Prod Commun. 2012 Oct;7(10):1351-2.
    Thymofolinoates A and B, new cinnamic acid derivatives from Euphorbia thymifolia.[Pubmed: 23157007]
    Two new cinnamic acid derivatives, thymofolinoates A (1) and B (2) have been isolated from the chloroform soluble fraction of Euphorbia thymifolia and their structures assigned from 1H and 13C NMR spectra, DEPT and by 2 D COSY, HMQCand H MBC experiments. In addition, p-hydroxy-cinnamic acid(3), 5-hydroxy-6,7,8,4'-tetramethoxy flavone (4), and 5-hydroxy-3',4',6,7,8-pentamethoxy flavone (5) have also been isolated for the first time from this species.
    In vivo:
    Mol Med Rep. 2009 Jul-Aug;2(4):641-4.
    The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts.[Pubmed: 21475879]
    The carotene p-hydroxycinnamic acid and the xanthophyll β-cryptoxanthin are members of the carotenoid family of plant-derived pigments, which are endowed with anti-osteoporotic properties in vivo. p-Hydroxycinnamic acid and β-cryptoxanthin have been demonstrated to stimulate osteoblastic bone formation while simultaneously repressing osteoclastic bone resorption in vitro. However, their mechanisms of action remain poorly elucidated. It is well established that the NF-;kgr;B signal transduction pathway plays a critical role in osteoclast differentiation. Moreover, we recently demonstrated that NF-κB activity potently antagonizes osteoblastic differentiation and mineralization in vitro.
    METHODS AND RESULTS:
    In this study, we used transient transfection assays of a NF-κB luciferase reporter to demonstrate that p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblastic cells.
    CONCLUSIONS:
    The data obtained suggest that NF-κB may be a common molecular target by which several bone active agents, including carotenoids, promote osteoblastic bone formation.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 6.0916 mL 30.4581 mL 60.9162 mL 121.8324 mL 152.2904 mL
    5 mM 1.2183 mL 6.0916 mL 12.1832 mL 24.3665 mL 30.4581 mL
    10 mM 0.6092 mL 3.0458 mL 6.0916 mL 12.1832 mL 15.229 mL
    50 mM 0.1218 mL 0.6092 mL 1.2183 mL 2.4366 mL 3.0458 mL
    100 mM 0.0609 mL 0.3046 mL 0.6092 mL 1.2183 mL 1.5229 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    4-甲氧基肉桂酸; 4-Methoxycinnamic acid CFN98191 830-09-1 C10H10O3 = 178.18 20mg QQ客服:1413575084
    顺式-香豆酸-4-葡萄糖苷; 4-O-beta-Glucopyranosyl-cis-coumaric acid CFN93803 117405-48-8 C15H18O8 = 326.29 5mg QQ客服:2932563308
    4-羟基肉桂酸甲酯; Methyl 4-hydroxycinnamate CFN96113 19367-38-5 C10H10O3 = 178.2 20mg QQ客服:3257982914
    对香豆酸乙酯; p-Coumaric acid ethyl ester CFN97218 7362-39-2 C11H12O3 = 192.2 20mg QQ客服:2932563308
    对甲氧基肉桂酸乙酯; Ethyl 4-methoxycinnamate CFN98180 24393-56-4 C12H14O3 = 206.24 20mg QQ客服:2932563308
    3-(4-甲氧基苯基)丙酸甲酯; Methyl 3-(4-methoxyphenyl)propanoate CFN96152 15823-04-8 C11H14O3 = 194.2 5mg QQ客服:3257982914
    Ethyl 3-(4-methoxyphenyl)propanoate; Ethyl 3-(4-methoxyphenyl)propanoate CFN96138 22767-72-2 C12H16O3 = 208.3 5mg QQ客服:1413575084
    4-羟基苯基乳酸甲酯; Methyl p-hydroxyphenyllactate CFN96379 51095-47-7 C10H12O4 = 196.2 5mg QQ客服:2159513211
    3-(4-羟基苯基)乳酸乙酯; Ethyl p-hydroxyphenyllactate CFN96363 62517-34-4 C11H14O4 = 210.2 5mg QQ客服:2159513211
    2,3-二羟基-3-(4-羟基苯基)丙酸; 2,3-dihydroxy-3-(4-hydroxyphenyl)propanoic acid CFN99018 100201-57-8 C9H10O5 = 198.2 5mg QQ客服:3257982914

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产